Doliente, Luzviminda B.

HRN: 00-57-44  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/24/2024
CIPROFLOXACIN 500MG (TAB)
08/24/2024
08/31/2024
PO
500mg
BID
Complicated Uti
Waiting Final Action 
08/25/2024
CEFTRIAXONE 1G (VIAL)
08/25/2024
09/01/2024
IV
2g
OD
CAP MR ;UTI
Waiting Final Action 
08/25/2024
AZITHROMYCIN 500MG TABLET (TAB)
08/25/2024
08/29/2024
ORAL
500mg/tab
OD
CAP MR
Waiting Final Action 
08/28/2024
CEFIXIME 200MG (CAP)
08/28/2024
09/04/2024
PO
200mg
Q12
CAP MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: